These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 15500863)

  • 21. Death to the bad guys: targeting cancer via Apo2L/TRAIL.
    Bouralexis S; Findlay DM; Evdokiou A
    Apoptosis; 2005 Jan; 10(1):35-51. PubMed ID: 15711921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of cell death ligand and receptor system on regulation of follicular atresia in pig ovaries.
    Manabe N; Matsuda-Minehata F; Goto Y; Maeda A; Cheng Y; Nakagawa S; Inoue N; Wongpanit K; Jin H; Gonda H; Li J
    Reprod Domest Anim; 2008 Jul; 43 Suppl 2():268-72. PubMed ID: 18638134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TRAF1: lord without a RING.
    Zapata JM; Reed JC
    Sci STKE; 2002 May; 2002(133):pe27. PubMed ID: 12023442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How do tumor necrosis factor receptors work?
    Bazzoni F; Beutler B
    J Inflamm; 1995; 45(4):221-38. PubMed ID: 8867667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-function relationship of inhibitory Smads: Structural flexibility contributes to functional divergence.
    Hariharan R; Pillai MR
    Proteins; 2008 Jun; 71(4):1853-62. PubMed ID: 18175316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in the molecular basis of TNF signal transduction.
    Ledgerwood EC; Pober JS; Bradley JR
    Lab Invest; 1999 Sep; 79(9):1041-50. PubMed ID: 10496522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Looking beyond death: a morphogenetic role for the TNF signalling pathway.
    Mathew SJ; Haubert D; Krönke M; Leptin M
    J Cell Sci; 2009 Jun; 122(Pt 12):1939-46. PubMed ID: 19494121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Palmitoylation of the TRAIL receptor DR4 confers an efficient TRAIL-induced cell death signalling.
    Rossin A; Derouet M; Abdel-Sater F; Hueber AO
    Biochem J; 2009 Apr; 419(1):185-92, 2 p following 192. PubMed ID: 19090789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TNF-receptor I defective in internalization allows for cell death through activation of neutral sphingomyelinase.
    Neumeyer J; Hallas C; Merkel O; Winoto-Morbach S; Jakob M; Thon L; Adam D; Schneider-Brachert W; Schütze S
    Exp Cell Res; 2006 Jul; 312(11):2142-53. PubMed ID: 16631736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor necrosis factor signaling mechanisms.
    Goeddel DV
    Harvey Lect; 1996-1997; 92():41-54. PubMed ID: 15372742
    [No Abstract]   [Full Text] [Related]  

  • 31. [The possible role of plasma membranes receptor domains in the mechanisms of cell differentiation and proliferation, and the control over these processes by specific receptor ligands].
    Talako SA
    Biofizika; 1997; 42(6):1247-59. PubMed ID: 9490111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of death receptor signaling in mechanical stretch-induced cardiomyocyte apoptosis.
    Liao X; Wang X; Gu Y; Chen Q; Chen LY
    Life Sci; 2005 May; 77(2):160-74. PubMed ID: 15862601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zfra affects TNF-mediated cell death by interacting with death domain protein TRADD and negatively regulates the activation of NF-kappaB, JNK1, p53 and WOX1 during stress response.
    Hong Q; Hsu LJ; Schultz L; Pratt N; Mattison J; Chang NS
    BMC Mol Biol; 2007 Jun; 8():50. PubMed ID: 17567906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular mechanism of TNF signaling and beyond.
    Liu ZG
    Cell Res; 2005 Jan; 15(1):24-7. PubMed ID: 15686622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative modeling of TNFRSF25 (DR3) predicts receptor destabilization by a mutation linked to rheumatoid arthritis.
    Borysenko CW; Furey WF; Blair HC
    Biochem Biophys Res Commun; 2005 Mar; 328(3):794-9. PubMed ID: 15694416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TNF signaling: early events and phosphorylation.
    Ihnatko R; Kubes M
    Gen Physiol Biophys; 2007 Sep; 26(3):159-67. PubMed ID: 18063842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Balancing co-stimulation and inhibition with BTLA and HVEM.
    Murphy KM; Nelson CA; Sedý JR
    Nat Rev Immunol; 2006 Sep; 6(9):671-81. PubMed ID: 16932752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of small molecules that sensitize resistant tumor cells to tumor necrosis factor-family death receptors.
    Schimmer AD; Thomas MP; Hurren R; Gronda M; Pellecchia M; Pond GR; Konopleva M; Gurfinkel D; Mawji IA; Brown E; Reed JC
    Cancer Res; 2006 Feb; 66(4):2367-75. PubMed ID: 16489043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological activities of reverse signal transduction through CD137 ligand.
    Schwarz H
    J Leukoc Biol; 2005 Mar; 77(3):281-6. PubMed ID: 15618293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding.
    Groppe J; Hinck CS; Samavarchi-Tehrani P; Zubieta C; Schuermann JP; Taylor AB; Schwarz PM; Wrana JL; Hinck AP
    Mol Cell; 2008 Feb; 29(2):157-68. PubMed ID: 18243111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.